Literature DB >> 22546638

Airway bacterial colonization: the missing link between COPD and cardiovascular events?

Salvatore Fuschillo1, Michele Martucci, Claudio F Donner, Giovanni Balzano.   

Abstract

BACKGROUND: Chronic obstructive pulmonary disease (COPD) is the fourth leading cause of death worldwide and, according to the World Health Organization, its prevalence will double by 2020. COPD is a chronic inflammatory disease of the lung characterized by poorly reversible airflow limitation and, frequently, by extrapulmonary manifestations. In particular, the cardiovascular manifestations are responsible for high morbidity and mortality. METHODS AND
RESULTS: A systematic literature search was performed of studies published in Medline until December 2010, using the key-words: COPD, bacterial colonization, COPD exacerbation, atherosclerosis, systemic inflammation, cardiovascular event and risk factors. In addition to the studies identified in the primary search, reference lists of included articles were analyzed for additional papers related to the topic. The pathogenetic mechanisms underlying atherosclerosis - namely inflammation, oxidative stress and endothelial dysfunction - are in common with COPD. Moreover, they are increased in the presence of COPD, especially in patients who present airway bacterial colonization, increased rate of exacerbations and elevated levels of both airway and systemic inflammation.
CONCLUSION: COPD is associated with an increased burden of atherosclerotic disease. Systemic inflammation and oxidative stress play key roles in this association. COPD patients with airway bacterial colonization, as compared to patients without airway colonization, generally present more frequent exacerbations and higher levels of both airway and systemic inflammation. This COPD subgroup should be considered at particularly increased risk of developing cardiovascular complications and receive more attention concerning diagnosis, treatment, prevention and research.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22546638     DOI: 10.1016/j.rmed.2012.03.023

Source DB:  PubMed          Journal:  Respir Med        ISSN: 0954-6111            Impact factor:   3.415


  10 in total

Review 1.  Predictors of cardiovascular risk in women.

Authors:  Tamer Sallam; Karol E Watson
Journal:  Womens Health (Lond)       Date:  2013-09

2.  Differences in clinical characteristics, management and short-term outcome between acute heart failure patients chronic obstructive pulmonary disease and those without this co-morbidity.

Authors:  John T Parissis; Chiara Andreoli; Nikolaos Kadoglou; Ignatios Ikonomidis; Dimitrios Farmakis; Ioanna Dimopoulou; Efstathios Iliodromitis; Maria Anastasiou-Nana; Mitja Lainscak; Giussepe Ambrosio; Alexandre Mebazaa; Gerasimos Filippatos; Ferenc Follath
Journal:  Clin Res Cardiol       Date:  2014-04-10       Impact factor: 5.460

3.  Comparison between cigarette smoke-induced emphysema and cigarette smoke extract-induced emphysema.

Authors:  Zhi-Hui He; Ping Chen; Yan Chen; Sheng-Dong He; Ji-Ru Ye; Hong-Liang Zhang; Jun Cao
Journal:  Tob Induc Dis       Date:  2015-03-25       Impact factor: 2.600

4.  Repeated lipopolysaccharide exposure causes corticosteroid insensitive airway inflammation via activation of phosphoinositide-3-kinase δ pathway.

Authors:  Keitaro Ueda; Yuki Nishimoto; Genki Kimura; Takashi Masuko; Peter J Barnes; Kazuhiro Ito; Yasuo Kizawa
Journal:  Biochem Biophys Rep       Date:  2016-07-28

5.  Microbiological airway colonization in COPD patients with severe emphysema undergoing endoscopic lung volume reduction.

Authors:  Franziska C Trudzinski; Frederik Seiler; Heinrike Wilkens; Carlos Metz; Annegret Kamp; Robert Bals; Barbara Gärtner; Philipp M Lepper; Sören L Becker
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2017-12-19

6.  Endotype-driven prediction of acute exacerbations in chronic obstructive pulmonary disease (EndAECOPD): protocol for a prospective cohort study.

Authors:  Wei Xiao; Long-Yi Du; Bing Mao; Ti-Wei Miao; Juan-Juan Fu
Journal:  BMJ Open       Date:  2019-11-04       Impact factor: 2.692

7.  Long-Term Risk of Mortality Associated with Isolation of Pseudomonas aeruginosa in COPD: A Systematic Review and Meta-Analysis.

Authors:  Miguel Angel Martinez-García; David Rigau; Miriam Barrecheguren; Alberto García-Ortega; Alexa Nuñez; Grace Oscullo Yepez; Marc Miravitlles
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2022-02-16

8.  Inflammatory thresholds and the species-specific effects of colonising bacteria in stable chronic obstructive pulmonary disease.

Authors:  Richa Singh; Alexander J Mackay; Anant Rc Patel; Davinder S Garcha; Beverly S Kowlessar; Simon E Brill; Louise E Donnelly; Peter J Barnes; Gavin C Donaldson; Jadwiga A Wedzicha
Journal:  Respir Res       Date:  2014-09-14

Review 9.  Diagnosis, assessment, and phenotyping of COPD: beyond FEV₁.

Authors:  Peter Lange; David M Halpin; Denis E O'Donnell; William MacNee
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2016-02-19

10.  Arterial stiffness in adults with steady-state bronchiectasis: association with clinical indices and disease severity.

Authors:  Yong-Hua Gao; Juan-Juan Cui; Ling-Yun Wang; Ke-Qin Yin; Li Wang; Guo-Jun Zhang; Shao-Xia Liu
Journal:  Respir Res       Date:  2018-05-09
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.